clinical trial semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo- controlled, phase 3 Semaglutide Safely Improves Metabolic Health

Semaglutide, a GLP-1 agonist, primarily aims to improve glycemic control for those managing type 2 diabetes and obesity

Sublingual administration is much simpler

Those who live an active lifestyle or exercise will generally take a form of whey protein following their workouts to help with the recovery process to support lean muscle mass

Solving Muscle Cramps By Addressing the Electrolyte Connection Increasing your water intake is a great way to reduce the risk of dehydration as an athlete on GLP-1 weight loss drugs

When GLP-1 medication is also slowing your digestion, the two effects may compound, making nausea feel more noticeable

Exenatide extended-release (ER) injection (Byetta, Bydureon), liraglutide ER injection (Victoza, Saxenda), and dulaglutide ER injection (Trulicity) are some of the long-acting injectable incretin mimetics that have been approved by U.S